Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
59.85
+2.16 (3.74%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.57 billion as of July 17, 2026. Its market cap has increased by 47.51% in one year.
Market Cap
2.57B
Enterprise Value
2.27B
1-Year Change
47.51%
Ranking
Category
Stock Price
$59.85
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.57B, an increase of 735.64%. That is a compound annual growth rate of 44.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 2.57B | -25.92% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 2.77B |
| Vera Therapeutics | 2.76B |
| Beam Therapeutics | 2.74B |
| Trevi Therapeutics | 2.71B |
| AtaiBeckley | 2.67B |
| Kodiak Sciences | 2.66B |
| SELLAS Life Sciences Group | 2.59B |
| Immunome | 2.53B |